Lumos Diagnostics Holdings Ltd Ordinary Shares LDXHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.06
- Day Range
- $0.06–0.06
- 52-Week Range
- $0.06–0.24
- Bid/Ask
- $0.00 / $4,000.11
- Shares Outstanding
- 988.17M
- Market Cap
- $54.05M
- Volume/Avg
- 10,000 / 41,518
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3.61
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Lumos Diagnostics Holdings Ltd is engaged in selling Products and providing Services to customers. Its product offering includes rapid, point-of-care diagnostic test products, mainly focused on the diagnosis and management of infectious diseases. Its product is FebriDx, a point-of-care test for detecting and differentiating viral and bacterial respiratory infections. Its Service offering includes contract research and development services specialising in innovation, development, manufacturing and commercialisation of point-of-care diagnostic test solutions. The Company has one operating segment, being the provision of point-of-care diagnostics goods and services. It operates in the United States and Australia, with the majority of revenue generated from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.lumosdiagnostics.com
Valuation
|
Metric
|
LDXHF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.42 |
Price/Sales | 3.61 |
Price/Cash Flow | 46.91 |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
LDXHF
|
|---|---|
Quick Ratio | 1.25 |
Current Ratio | 1.52 |
Interest Coverage | −1.45 |
Quick Ratio
LDXHF
Profitability
|
Metric
|
LDXHF
|
|---|---|
Return on Assets (Normalized) | −40.70% |
Return on Equity (Normalized) | −98.23% |
Return on Invested Capital (Normalized) | −51.57% |
Return on Assets
LDXHF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|w>bWKg | LOCK|@&Jb | $179B | |||
| Medtronic PLC
MDT
| LOCK|#Br!!y | LOCK|&qS^ | $122B | |||
| Stryker Corp
SYK
| LOCK|%n^hgSj | LOCK|pz | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|k^#SQc | LOCK|&NVG | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|#htVsY< | LOCK|yK<^W | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|s&??&J | LOCK|<y? | $32B | |||
| DexCom Inc
DXCM
| LOCK|z&Qfyd< | LOCK|%Dg# | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|nt | LOCK|nZ | $26B | |||
| Steris PLC
STE
| LOCK|^n?psH | LOCK|z&@m | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|rYvq>V# | LOCK|c& | $19B |
United States